Araştırma Makalesi

How does the presence of the pathologist affect the tissue adequacy and what are the factors affecting the pathologist in proficiency assessment, during percutaneous kidney biopsy?

Cilt: 45 Sayı: 2 30 Haziran 2023
Cumhuriyet Tıp Dergisi Kapak
Cumhuriyet Tıp Dergisi
PDF İndir
EN

How does the presence of the pathologist affect the tissue adequacy and what are the factors affecting the pathologist in proficiency assessment, during percutaneous kidney biopsy?

Abstract

Objectives: For optimal histomorphological examination, adequacy of kidney biopsy tissue should be obtained. In this study, the effect of a pathologist informing the radiologist about tissue adequacy during the biopsy procedure on obtaining tissue adequacy was examined. Furthermore, we aimed to determine the criteria that the pathologist considered in determining tissue adequacy and the conditions affecting the decision to increase the number of core biopsies, as these have not been previously examined in the literature. Materials and Methods: Tissues containing less than 10 glomeruli were considered inadequate. In some patients, a pathologist accompanied the radiologist during the procedure. Tissue adequacy ratios and biopsy sample numbers were calculated between the two conditions. In the samples taken with the pathologist, the factors affecting the locality decision of the pathologist (cortex/medulla amount, presence of glomerular pathology(global, segmental, crescentic glomeruli) presence of tubular injury, proteinuria; interstitial inflammation and interstitial fibrosis/tubular atrophy ratios, account of normal glomeruli) were examined. Results: Giving tissue adequacy information during the biopsy procedure had a positive effect on tissue adequacy. The amount of cortex is one of the qualification criteria for the pathologist. The presence of proteinuria and 50% or more inflammation in tissues with sufficient cortex increased the number of biopsy samples. Conclusion: Determination of tissue adequacy during kidney biopsy is an important and necessary method. The amount of cortex is one of the important parameters in tissue adequacy.

Keywords

Kaynakça

  1. 1. Appel GB, Silva FG, Pirani CL, Meltzer JI, Estes D. Renal involvement in systemic lupud erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Medicine 1978; 57: 371–410.
  2. 2. Whittier WL, Korbet SM. Renal biopsy: update. Curr Opin Nephrol Hypertens. 2004; 13: 661-65. 3. Korbet SM. Percutaneous renal biopsy. Semin Nephrol 2002; 22(03): 254–67.
  3. 4. Kajawo S, Moloi MW, Noubiap JJ, Ekrikpo U, Kengne AP, Okpechi IG. Incidence of major complications after percutaneous native renal biopsies in adults from low-income to middle in come countries: a protocol for systematic review and meta-analysis. BMJ Open 2018; 8(4): e020891.
  4. 5. Trajceska L, Andreevska GS, Vidimliski PD, Nikolov I, Selim G, Spasovski G, et al. Complications and Risks of Percutaneous Renal Biopsy. Macedonian Journal of Medical Sciences 2019; 7(6): 992-95.
  5. 6. Constantin A, Brisson ML, Kwan J, Proulx F. Percutaneous US-guided renal biopsy: a retrospective study comparing the 16-gauge end-cut and 14-gauge side-notch needles. J Vasc Interv Radiol 2010; 21: 357–61.
  6. 7. J. Hogan J, Mocanu M, Berns JS. The Native Kidney Biopsy: Update and Evidence for Best Practice. Clin J Am Soc Nephrol 2016; 11(2): 354-62.
  7. 8. Kim D, Kim H, Shin G, et al. A randomized, prospective, comparative study of manual and automated renal biopsies. Am J Kidney Dis 1998; 32: 426–31. 9.Amoueian S, Attaranzadeh A. Renal Biopsy Interpretation: In Topics in Renal Biopsy and Pathology. Edited by Mubarak M. Croatia: InTech, 2012: 45–64. 10.Gauthier BG, Mahadeo RS, Trachtman H. Techniques for percutaneous renal biopsies. Pediatr Nephrol 1993; 7: 457–63. 11. Sharma SG, Arthur JM, Bonsib SM, et al. An integrated pathology and ultrasonography based simulation for training in performing kidney biopsy. Clinical Nephrology 2018; 89(3): 214-22. 12.Esposito V, Mazzon G, Baiardi P, et al. Safety and adequacy of percutaneous kidney biopsy performed by nephrology trainees. BMC Nephrology 2018; 19: 14.
  8. 13.Reschen ME, Mazzella A, Sharples E. A retrospective analysis of the utility and safety of kidney transplant biopsies by nephrology trainees and consultants. Annals of Medicine and Surgery 2018; 28: 6–10. 14.Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B. Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clinical Kidney Journal 2017; 10(4): 573–77.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Sağlık ve Toplum Hizmetleri

Bölüm

Araştırma Makalesi

Yazarlar

Erken Görünüm Tarihi

30 Haziran 2023

Yayımlanma Tarihi

30 Haziran 2023

Gönderilme Tarihi

18 Haziran 2023

Kabul Tarihi

23 Haziran 2023

Yayımlandığı Sayı

Yıl 2023 Cilt: 45 Sayı: 2

DOI

https://doi.org/10.7197/cmj.1316057

IZ

https://izlik.org/JA23UY59ZM

Kaynak Göster

RIS / Bibtex
AMA
1.Kaya Ş, Şenol A, Kutlar Dursun FŞ, Çelikgün S. How does the presence of the pathologist affect the tissue adequacy and what are the factors affecting the pathologist in proficiency assessment, during percutaneous kidney biopsy? CMJ. 2023;45(2):59-66. doi:10.7197/cmj.1316057